2008
DOI: 10.1016/j.brainres.2008.03.033
|View full text |Cite
|
Sign up to set email alerts
|

PET O-15 cerebral blood flow and metabolism after acute stroke in spontaneously hypertensive rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 31 publications
1
19
0
Order By: Relevance
“…In the present study, only 0.2 mL of arterial blood was taken at each measurement, and the total volume of blood withdrawn was 0.5 mL. This volume was much smaller than that reported in previous studies (9,20). The small-volume sampling in this study was considered to have a negligible influence on systemic circulation.…”
Section: Discussionmentioning
confidence: 55%
See 3 more Smart Citations
“…In the present study, only 0.2 mL of arterial blood was taken at each measurement, and the total volume of blood withdrawn was 0.5 mL. This volume was much smaller than that reported in previous studies (9,20). The small-volume sampling in this study was considered to have a negligible influence on systemic circulation.…”
Section: Discussionmentioning
confidence: 55%
“…In previous PET studies, a bolus injection of 15 O-labeled water ( 15 O-H 2 O) was used for quantitative measurement of the CBF; the reported CBF values ranged from 35 to 51 mL/100 g/min (6,8,20). Kobayashi et al reported a steadystate method consisting of a bolus injection followed by injection of 15 O-H 2 O at slowly increasing doses with a multiprogramming syringe pump (9).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Consequently, we found that hypertension intensifies metabolic disturbances after the onset of strokes. [90][91][92][93] Thus injectable 15 O-O 2 could be used reliably to estimate oxygen metabolism in an infarction rat model with PET. Furthermore, we developed molecular probes for nuclear medicinal imaging targeting β-secretase in the brain, acetylcholine esterase, cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and hepatic organic anion transporter (OATP1B1).…”
Section: Tc or 186/188mentioning
confidence: 99%